AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11505696 — intervention group
Group type: COMPARATOR
Intervention: Butter (30 g total per day, 15 g twice a day)
Number of subjects: 83
Study 9752402 — intervention group
Group type: EXPERIMENTAL
Intervention: Shouldice repair (S group)
Number of subjects: 64
Study 9752402 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic repair (L group)
Number of subjects: 64
Study 7822582 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenic patients
Number of subjects: 60
Study 7822582 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed control patients
Number of subjects: 60
Study 7822582 — intervention group
Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 60
Study 3397041 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 8
Study 3397041 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 8
Study 3397041 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 8
Study 31650328 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fibre intake (39 g/day)
Number of subjects: 10
Study 31650328 — intervention group
Group type: COMPARATOR
Intervention: Low-fibre intake (18 g/day)
Number of subjects: 10
Study 31368270 — intervention group
Group type: EXPERIMENTAL
Intervention: Headache-acupoint group
Number of subjects: 40
Study 31368270 — intervention group
Group type: COMPARATOR
Intervention: Sham-acupoint group
Number of subjects: 40
Study 28905240 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 39
Study 28905240 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 39
Study 28905240 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed (aerobic and resistance) training
Number of subjects: 39
Study 28905240 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study 25037189 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased intake of resistant starch (RS) and wheat bran (WB)
Number of subjects: 19
Study 25037189 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects), n=10
Number of subjects: 19
Study 25037189 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing RS/WB intake
Number of subjects: 19
Study 25037189 — intervention group
Group type: EXPERIMENTAL
Intervention: Faeces from UC cohort
Number of subjects: 19
Study 23862170 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-day triple therapy
Number of subjects: 314
Study 23862170 — intervention group
Group type: COMPARATOR
Intervention: 7-day triple therapy
Number of subjects: 314
Study 23862170 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-day triple therapy (subgroup)
Number of subjects: 314
Study 23862170 — intervention group
Group type: COMPARATOR
Intervention: 7-day triple therapy (subgroup)
Number of subjects: 314
Study 21781448 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertion torque of 35N
Number of subjects: 20
Study 21781448 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertion torque of 50N
Number of subjects: 20
Study 21781448 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertion torque of 65N
Number of subjects: 20
Study 21781448 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertion torque of 85N
Number of subjects: 20
Study 21781448 — intervention group
Group type: COMPARATOR
Intervention: Control group (insertion torque of 35N and 50N)
Number of subjects: 20
Study 21781448 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (insertion torque of 65N and 85N)
Number of subjects: 20
Study 17934721 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg of nicotine delivered via nasal spray
Number of subjects: 0
Study 17934721 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17934721 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative arousal from an unsolvable anagram task
Number of subjects: 0
Study 17071438 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) 2 g/day
Number of subjects: 100
Study 17071438 — intervention group
Group type: COMPARATOR
Intervention: Medroxyprogesterone acetate (MPA) 10 mg twice-daily
Number of subjects: 100
Study 12940394 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose nicotine patch (35 mg)
Number of subjects: 158
Study 12940394 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 158
Study 10740110 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenspiride (Pneumorel 80mg) plus antibiotic therapy (Amoxicillin 500mg plus clavulanic acid 125, 3 tablets/day)
Number of subjects: 39
Study 10740110 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus antibiotic therapy (Amoxicillin 500mg plus clavulanic acid 125, 3 tablets/day)
Number of subjects: 39
Study 9200635 — intervention group
Group type: EXPERIMENTAL
Intervention: Levomethadyl acetate hydrochloride (LAAM) high-dose condition (100/100/140 mg)
Number of subjects: 180
Study 9200635 — intervention group
Group type: EXPERIMENTAL
Intervention: Levomethadyl acetate hydrochloride (LAAM) medium-dose condition (50/50/70 mg)
Number of subjects: 180
Study 9200635 — intervention group
Group type: EXPERIMENTAL
Intervention: Levomethadyl acetate hydrochloride (LAAM) low-dose condition (25/25/35 mg)
Number of subjects: 180
Study 8261875 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of methadone
Number of subjects: 95
Study 8261875 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of methadone
Number of subjects: 95
Study 8261875 — intervention group
Group type: COMPARATOR
Intervention: methadone-free treatment
Number of subjects: 95
Study 6383114 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefopam
Number of subjects: 42
Study 6383114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 31215440 — intervention group
Group type: EXPERIMENTAL
Intervention: QbTest added to medication management
Number of subjects: 21
Study 29843676 — intervention group
Group type: EXPERIMENTAL
Intervention: Intake of typical antipsychotics
Number of subjects: 127
Study 29843676 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 127
Study 29843676 — intervention group
Group type: EXPERIMENTAL
Intervention: Being employed
Number of subjects: 127
Study 29843676 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher level of global functioning
Number of subjects: 127
Study 29843676 — intervention group
Group type: EXPERIMENTAL
Intervention: Having social support
Number of subjects: 127
Study 29843676 — intervention group
Group type: COMPARATOR
Intervention: Female sex
Number of subjects: 127
Study 27084979 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 - referred to as 'people/person with epilepsy'
Number of subjects: 234
Study 27084979 — intervention group
Group type: COMPARATOR
Intervention: Group 2 - referred to as 'epileptic/s'
Number of subjects: 234
Study 25312554 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of insulin (group 1)
Number of subjects: 30
Study 25312554 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous injections of insulin glargine (group 2)
Number of subjects: 30
Study 25312554 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin dosage during 6-month follow-up
Number of subjects: 30
Study 20522796 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent subglottic secretion drainage (SSD)
Number of subjects: 333
Study 20522796 — intervention group
Group type: COMPARATOR
Intervention: Control (no SSD)
Number of subjects: 333
Study 16135587 — intervention group
Group type: EXPERIMENTAL
Intervention: 17alpha‐hydroxyprogesterone caproate
Number of subjects: 463
Study 16135587 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 463
Study 11491011 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC) 6 mg/kg
Number of subjects: 26800
Study 11491011 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin 400 micrograms/kg
Number of subjects: 26800
Study 11491011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26800
Study 9554833 — intervention group
Group type: EXPERIMENTAL
Intervention: Diluted diesel exhaust (300mg m(‐3) particulates, 1.6ppm nitrogen dioxide)
Number of subjects: 15
Study 9554833 — intervention group
Group type: COMPARATOR
Intervention: Filtered air
Number of subjects: 15
Study 8089358 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrel implant
Number of subjects: 0
Study 2782121 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 15
Study 4603999 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg prednisone, daily for a week
Number of subjects: 10
Study 4603999 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 29916784 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic information about PSA screening
Number of subjects: 1208
Study 29916784 — intervention group
Group type: EXPERIMENTAL
Intervention: Didactic information about screening risks and benefits
Number of subjects: 1208
Study 29916784 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative stories about physical harm, emotional harm, overdiagnosis, or all 3 stories
Number of subjects: 1208
Study 27383558 — intervention group
Group type: EXPERIMENTAL
Intervention: mRDTs used by CHWs
Number of subjects: 1355
Study 27383558 — intervention group
Group type: COMPARATOR
Intervention: Presumptive diagnosis by CHWs
Number of subjects: 1355
Study 24655464 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group
Number of subjects: 82
Study 24655464 — intervention group
Group type: COMPARATOR
Intervention: Bibliotherapy
Number of subjects: 82
Study 24655464 — intervention group
Group type: COMPARATOR
Intervention: Brochure control
Number of subjects: 82
Study 22855914 — intervention group
Group type: EXPERIMENTAL
Intervention: UHV-HPMC (4 g)
Number of subjects: 12
Study 22855914 — intervention group
Group type: EXPERIMENTAL
Intervention: Psyllium fiber (4 g)
Number of subjects: 12
Study 22855914 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 20471544 — intervention group
Group type: EXPERIMENTAL
Intervention: Handheld fan directed to the face
Number of subjects: 50
Study 20471544 — intervention group
Group type: COMPARATOR
Intervention: Handheld fan directed to the leg
Number of subjects: 50
Study 18331577 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical case management group (CMG)
Number of subjects: 370
Study 18331577 — intervention group
Group type: COMPARATOR
Intervention: Standard care group (SCG)
Number of subjects: 370
Study 18331577 — intervention group
Group type: COMPARATOR
Intervention: No-treatment group (NTG)
Number of subjects: 370
Study 16435701 — intervention group
Group type: EXPERIMENTAL
Intervention: Horn sounds recorded in three test vehicles presented in quiet
Number of subjects: 20
Study 16435701 — intervention group
Group type: EXPERIMENTAL
Intervention: Horn sounds recorded in three test vehicles presented with engine idling, fan off
Number of subjects: 20
Study 16435701 — intervention group
Group type: EXPERIMENTAL
Intervention: Horn sounds recorded in three test vehicles presented with engine idling, fan on
Number of subjects: 20
Study 16435701 — intervention group
Group type: EXPERIMENTAL
Intervention: Horn sounds recorded in three test vehicles presented while vehicle moving at 30 mph, fan off
Number of subjects: 20
Study 16435701 — intervention group
Group type: EXPERIMENTAL
Intervention: Horn sounds recorded in three test vehicles presented while vehicle moving at 30 mph, fan on
Number of subjects: 20
Study 12907528 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation plus inhaled ipratropium bromide
Number of subjects: 5887
Study 12907528 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation plus placebo inhaler
Number of subjects: 5887
Study 12907528 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 5887
Study 10097995 — intervention group
Group type: EXPERIMENTAL
Intervention: Autistic individuals
Number of subjects: 30
Study 10097995 — intervention group
Group type: EXPERIMENTAL
Intervention: Down individuals
Number of subjects: 30
Study 10097995 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal development)
Number of subjects: 30
Study 10097995 — intervention group
Group type: EXPERIMENTAL
Intervention: Identity and emotional situation subtasks
Number of subjects: 30
Study 8904946 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Self‐Change (GSC)
Number of subjects: 788
Study 8904946 — intervention group
Group type: COMPARATOR
Intervention: Educational Materials Control (EMC)
Number of subjects: 788
Study 1867242 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with hypertension
Number of subjects: 265
Study 1867242 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients older than 75 years
Number of subjects: 265
Study 1867242 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with both hypertension and age over 75 years
Number of subjects: 265
Study 1867242 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonrheumatic atrial fibrillation without stroke)
Number of subjects: 265
Study 6139327 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluspirilene
Number of subjects: 82
Study 6139327 — intervention group
Group type: COMPARATOR
Intervention: Bromazepam
Number of subjects: 82
Study 29651668 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan nanoparticle
Number of subjects: 60
Study 29651668 — intervention group
Group type: EXPERIMENTAL
Intervention: QMix
Number of subjects: 60
Study 29651668 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTA
Number of subjects: 60
Study 29651668 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 60
Study 29412705 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE)
Number of subjects: 41
Study 29412705 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined exercise (CE)
Number of subjects: 41
Study 27527344 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive transfusion threshold (eligible for transfusion if post-operative haemoglobin < 7.5 g/dl)
Number of subjects: 2007
Study 27527344 — intervention group
Group type: COMPARATOR
Intervention: Liberal transfusion threshold (eligible for transfusion immediately after randomisation if post-operative haemoglobin < 9 g/dl)
Number of subjects: 2007
Study 27527344 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive transfusion threshold
Number of subjects: 2007
Study 27527344 — intervention group
Group type: COMPARATOR
Intervention: Liberal transfusion threshold
Number of subjects: 2007
Study 24036678 — intervention group
Group type: EXPERIMENTAL
Intervention: Partners Together in Health (PaTH) intervention
Number of subjects: 34
Study 24036678 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 34
Study 24036678 — intervention group
Group type: EXPERIMENTAL
Intervention: PaTH intervention
Number of subjects: 34
Study 22869534 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional sphincterotomy (GI)
Number of subjects: 150
Study 22869534 — intervention group
Group type: EXPERIMENTAL
Intervention: V‐Y advancement flap (GII)
Number of subjects: 150
Study 22869534 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined tailored lateral sphincterotomy with V‐Y advancement flap (GIII)
Number of subjects: 150
Study 20336999 — intervention group
Group type: EXPERIMENTAL
Intervention: Trigger point acupuncture
Number of subjects: 21
Study 20336999 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine infiltration of trigger points
Number of subjects: 21
Study 17030104 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT) - estrogen plus progesterone
Number of subjects: 40
Study 17030104 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated women)
Number of subjects: 40
Study 15793193 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glucose tolerance test (OGTT) at baseline and after approximately 2 years
Number of subjects: 117
Study 15793193 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe obesity, impaired glucose tolerance, and African-American background
Number of subjects: 117
Study 15793193 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in insulin sensitivity related to weight change
Number of subjects: 117
Study 15793193 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting glucose, insulin, and C-peptide
Number of subjects: 117
Study 12226608 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching primer (Transbond Plus Self Etching Primer, 3M Unitek) left for 15 seconds before bonding
Number of subjects: 48
Study 12226608 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching primer (Transbond Plus Self Etching Primer, 3M Unitek) left for 2 minutes before bonding
Number of subjects: 48
Study 12226608 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching primer (Transbond Plus Self Etching Primer, 3M Unitek) left for 10 minutes before bonding
Number of subjects: 48
Study 12226608 — intervention group
Group type: COMPARATOR
Intervention: Conventional etchant and separate primer (control group)
Number of subjects: 48
Study 10654357 — intervention group
Group type: EXPERIMENTAL
Intervention: HTK
Number of subjects: 959
Study 10654357 — intervention group
Group type: COMPARATOR
Intervention: UW
Number of subjects: 959
Study 10654357 — intervention group
Group type: COMPARATOR
Intervention: EC
Number of subjects: 959
Study 7792438 — intervention group
Group type: EXPERIMENTAL
Intervention: rhDNase 0.6, 2.5, 10 mg
Number of subjects: 968
Study 7792438 — intervention group
Group type: EXPERIMENTAL
Intervention: rhDNase 2.5 mg, once or twice daily
Number of subjects: 968
Study 7792438 — intervention group
Group type: COMPARATOR
Intervention: rhDNase
Number of subjects: 968
Study 7792438 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 968
Study 2235167 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone for 7 days plus trimethoprim-sulfamethoxazole (TMP/SMZ) for 30 days
Number of subjects: 53
Study 2235167 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (TMP/SMZ) alone
Number of subjects: 53
Study 2235167 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment (including crossover)
Number of subjects: 53
Study 2235167 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone plus TMP/SMZ
Number of subjects: 53
Study 2235167 — intervention group
Group type: COMPARATOR
Intervention: TMP/SMZ alone
Number of subjects: 53
Study 369049 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised oral hygiene action with amine fluoride-containing agents Silca and Elmex fluid
Number of subjects: 18
Study 31283565 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT)
Number of subjects: 139
Study 31283565 — intervention group
Group type: COMPARATOR
Intervention: Standard dressing (control)
Number of subjects: 139
Study 30394916 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐Hydroxy‐3‐Methylglutaryl‐CoA Reductase genetic score
Number of subjects: 832
Study 30394916 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprotein Convertase Subtilisin/Kexin type 9 genetic score
Number of subjects: 832
Study 30394916 — intervention group
Group type: COMPARATOR
Intervention: Low low‐density lipoprotein levels
Number of subjects: 832
Study 28777365 — intervention group
Group type: EXPERIMENTAL
Intervention: Reslip (doxylamine)
Number of subjects: 60
Study 28777365 — intervention group
Group type: COMPARATOR
Intervention: Donormyl
Number of subjects: 60